Can the Cancer and Leukemia Group B 140503 trial support choice of segmental versus wedge resection for non–small cell lung cancer?
Benjamin A.Y. Cher, Qinyun Lin, Kenneth A. Frank, James D. Maloney, Courtney J. Balentine, Andrea L. Axtell · 2026
Read Can the Cancer and Leukemia Group B 140503 trial support choice of segmental versus wedge resection for non–small cell lung cancer? by Benjamin A.Y. Cher, Qinyun Lin, Kenneth A. Frank, James D. Maloney, Courtney J. Balentine, Andrea L. Axtell (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13477055.txt.
Description
Benjamin A.Y. Cher and five colleagues tested in 2026 whether a post-hoc finding on lung cancer surgery is sturdy enough to guide practice. The CALGB 140503 trial supported smaller sublobar resection over lobe removal, but its post-hoc comparison of wedge resection against anatomic segmentectomy found no survival difference. Surgeons doubted it for hidden bias and small numbers.
The team applied robustness of inferences to replacement, which counts how many patients would need different outcomes to overturn a finding. The wedge-versus-segmentectomy result proved robust under that test. The authors present the method as a plainer guide than p-values for deciding whether post-hoc results should change practice.
Catalog record
| CREATOR | Benjamin A.Y. Cher, Qinyun Lin, Kenneth A. Frank, James D. Maloney, Courtney J. Balentine, Andrea L. Axtell |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |